EUA

PREMIUM CONTENT

Eurasia Mining shares still sliding – 2 questions it MUST answer now

On 4 December 2020 shares in Russia PGM promote Eurasia Mining (LSE:EUA) hit 40.55p and morons across the interweb, spurred on by fraudulent paid for research and also by blatant market abuse by Good Germans, pondered what colours their fleets of Ferraris would be painted. Today the shares are just 5p after dire finals earlier this week. There are two big questions Eurasia needs to answer:

Subscribe to ShareProphets to access Premium Content

MHC

PREMIUM CONTENT

MyHealthChecked – first half ‘strong’ trading and new testing commercialisations potential excitement ahead

MyHealthChecked (MHC) has announced that trading in the first six months of the current year has been stronger than expected – and that ahead of launch of five at-home cheek swab DNA wellness tests.

Subscribe to ShareProphets to access Premium Content

CTEA

PREMIUM CONTENT

Catenae Innovation: Three Months Down, Three To Go As Unconvincing Financial Statement Offered

AIM-listed and now suspended for three months Catenae Innovation (CTEA) has offered up an update on its financial position as the clock ticks down to the arrival of the Fat Lady.

Subscribe to ShareProphets to access Premium Content

TSP

PREMIUM CONTENT

TruSpine Updates On Whereabouts Of Mr Godot (...or not)

He was coming by the end of 2020. Then he was going to appear during Q1 2021. Then Q2 2021. Then by the end of the year. And then by the close of Q2 2022 – ie yesterday…….and surprise, surprise, he hasn’t come. But he is most certainly coming tomorrow. Honest, guv’.

Subscribe to ShareProphets to access Premium Content

PREMIUM CONTENT

Tom Winnifrith Bearcast: The best time to kick a man is when he is down - Shield and Cineworld

I start with a few family reflections on my family and World War One. Then it is onto Optibiotix (OPTI) and misguided suggestions that regime change is needed. Finally I reflect on Evil Knievil's catch phrase with reference to Cineworld (CINE) but more especially Shield Therapeutics (STX)

Subscribe to ShareProphets to access Premium Content

SuperPowers Aren't Helping Share Prices, but the Pessimism Will Wear Off...Eventually.

Hello Share Scratchers. The Footsie’s not upwardly mobile these days. Let’s see why. Well, there’s a strong presence of that great enemy of share price progress: uncertainty. And most of that wobble is caused by the super powers. Russia’s behaviour is unacceptable and world will never forgive her. Yet Putin continues to want back the whole of the Soviet Block.

B90

B90 Holdings – “pleased to announce” broker appointment. Why might that be?

Online marketing and operating company for the gaming industry B90 Holdings (B90) “is pleased to announce the appointment of Arden Partners plc as its Corporate Broker with immediate effect”. That includes with the shares down from above 10p early this year to a current 4.5p and follows results announced last week.

PREMIUM CONTENT

Tom Winnifrith Bearcast: arguing with Steve O'Hara as we miss out on Darren the Leatherman and Lucian the cowboy

I apologise for ShareProphets not being big corporate and thus not celebrating Pride Month in a PLC and unconvincing manner. Next year. Or maybe not. Then it is on to my argument with Steve O'Hara at Optibiotix (OPTI). I do not regret buying more shares yesterday one iota but I am cross anyway. I explain this and then focused on something very fishy indeed at Dev Clever (DEV). Then I look at Ben's Creek (BEN) and a bit more on the Adam Wilson CV and why I am sure this will end in tears. Finally, an IPO: Alteration Earth (ALTE) and why you should avoid it like the plague.

Subscribe to ShareProphets to access Premium Content

ITX

Itaconix – “revenues substantially ahead”. Er, how’s the cash burn?

Describing itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) has issued an AGM statement emphasising “revenues substantially ahead of any prior half year. Demand has remained strong right into this week”. So what of a current 5.75p share price, circa £26 million market cap – approaching 30% ahead on this latest announcement from the company?

OPTI

PREMIUM CONTENT

OptiBiotix Health – 2021 results, clear upcoming share price potential from here; STRONG BUY

OptiBiotix Health (OPTI) has announced audited results for the 2021 calendar year and that it continues to make good progress against stated aims of focusing on a smaller number of large partners in key strategic markets and growing its direct-to-consumer sales.

Subscribe to ShareProphets to access Premium Content